Systemic inflammation is associated with sympathetic cardiac activation and decreased HRV (heart rate variability) in subjects at high risk of CAD (coronary artery disease). In the present study, we examined the influence of systemic inflammation, measured by CRP (C-reactive protein), on vagal HR (heart rate) control during behavioural relaxation in patients with CAD. It was hypothesized that CRP would be associated with decreased vagal HR modulation. Consecutive patients were screened 2 weeks prior to elective PTCA (percutaneous transluminal coronary angioplasty). The study was comprised of 29 subjects who represented the first and fourth quartiles of the CRP distribution: Low (0.47 + − 0.07 µg/ml)-and High (8.19 + − 1.95 µg/ml)-CRP groups respectively. Vagal HR control was quantified as RR high-frequency spectral power (0.15 to 0.40 Hz), and was assessed in log-transformed absolute units (logHF power). Near-IR particle immunoassay was used to determine high-sensitivity CRP concentration. Assessment entailed 5 min of silent reading and self-guided behavioural relaxation. RR logHF power was decreased in the High-CRP group across both assessment procedures (P = 0.032). Behavioural relaxation increased RR logHF power for both the Low-and High-CRP groups (P = 0.033). Hierarchical linear regression determined that CRP accounted for 18.9 % of the variance in RR logHF power during behavioural relaxation (P = 0.03), independent of baseline RR interval, cardiac medication, respiratory logHF power and body mass index. In conclusion, patients with CAD had augmented vagal HR control with behavioural relaxation, but this effect was moderated by the severity of CRP. Therefore it may be advisable to assess systemic inflammation in interventions aimed at improving neurocardiac regulation in patients with CAD.
INTRODUCTION
Vagal efferent control of HR (heart rate) is an important index of adaptive neurocardiac regulation. Among patients with CAD (coronary artery disease), vagal HR control is well known to exert a cardioprotective effect [1] . Decreased HRV (HR variability) reflects diminished vagal modulation of the sinus node cycle length due to withdrawal of vagal efferent activity, vagal inhibition due to sympathetic overactivity, or non-neural factors. HRV markers of decreased vagal HR control or cardiovagal baroreflex gain independently account for a higher prevalence of cardiac mortality and fatal arrhythmias following acute myocardial infarction [2, 3] .
Autonomic regulation of HR during laboratory and environmental challenges is characterized by an acute shift towards sympathetic activation and vagal HR inhibition, as measured by spectral analysis of HRV, BP (blood pressure) and BRS (baroreflex sensitivity) [4] . A heightened or prolonged cognitive-emotional response to these challenges may lower the threshold for neurogenic arrhythmia [5] [6] [7] . This acute adjustment is associated with increased levels of serum catecholamines and activation of the HPA (hypothalamic-pituitary-adrenal) axis, as measured by serum levels of cortisol [8, 9] . More recently, parallel changes in systemic inflammatory activity have also been observed during the acute stress response, as measured by pro-inflammatory cytokines, such as IL (interleukin)-6 and TNF-α (tumour necrosis factor-α), and the acute-phase reactant CRP (C-reactive protein) [10, 11] . Activation of the sympathetic nervous system and the HPA axis inhibit the inflammatory process, which protects against progressive injury to the arterial endothelium that is associated with uncontrolled inflammation. However, in chronic inflammatory conditions such as CAD, the continuous synthesis and release of proinflammatory agents may facilitate sustained sympathetic and HPA activation, with a potential negative impact on neurocardiac regulation. It is unclear whether the chronic inflammatory environment may compromise cognitivebehavioural coping responses, such as behavioural relaxation, that are aimed at augmenting vagal HR regulation.
The present study addressed two questions. First, do CAD patients demonstrate the capacity to significantly increase short-term vagal HR control in their spontaneous efforts to utilize behavioural relaxation? Secondly, given that the chronic inflammatory environment promotes sympathetic (neural) and HPA (humoral) activation [12, 13] , what is the impact of elevated systemic inflammation on vagal HR control? We hypothesized that patients with CAD with elevated CRP would show decreased vagal HR modulation during a behavioural assessment procedure, as inferred from HF (high-frequency) spectral power (0.15-0.40 Hz) in the analysis of HRV.
MATERIALS AND METHODS

Patients
This research was reviewed by the Research Ethics Boards of the participating institutions. All patients provided written informed consent. Results are presented from consecutively recruited patients with CAD, who were enrolled in a larger investigation examining psychological influences on platelet aggregation [14] .
Patients between 35 and 75 years of age were recruited from pre-admission clinics for elective PTCA (percutaneous transluminal coronary angioplasty). PTCA was scheduled within the subsequent 2 weeks. Exclusion criteria were myocardial infarction within the past 7 days, total vessel occlusion, angiographic evidence of intracoronary thrombosis and creatinine >180 mmol/l.
Procedures
Assessments were conducted between 08:00 and 12:00 hours. Patients were directed to refrain from caffeine or smoking for at least 4 h prior to their sessions. HRV assessments were conducted with patients in a semi-reclined position. Adaptation to the laboratory was followed by two successive 5-min procedures: silent reading of an emotionally 'neutral' text and self-guided behavioural relaxation. Silent reading was selected as the baseline task instead of an undirected 'resting baseline' to control for a degree of cognitive attention that was implicitly required for the self-guided relaxation procedure. During self-guided relaxation, patients were instructed to become as calm and relaxed as possible, while breathing spontaneously and refraining from speaking to the research assistant.
Measurement of disease severity
Angiograms were performed by a cardiologist, who was blinded to results of the CRP analysis and findings of the HRV assessment and psychometric testing. Coronary vessels were examined using standard morphological criteria, and single end-diastolic frames were selected to quantify lesion length and severity, using the Cardiac Measurement System (Medical Imaging Systems).
Measurement of CRP
Venous blood was drawn immediately prior to and following the HRV assessment. Plasma samples were stored at − 80
• C. Assays of high-sensitivity CRP concentration were determined by near-IR particle immunoassay, using a Beckman-Coulter Synchron LX20 analyser. CRP reagents were supplied by Beckman-Coulter.
Spectral analysis of HRV and respiration
Three ECG electrodes were attached to the chest in a standard three-lead configuration. Lead II signals were obtained and stored through the ProComp + monitoring system and Cardiopro software (Thought Technology). Analogue-to-digital conversion was performed at 256 samples/s. The raw ECG data were analysed offline using an M-file written in MATLAB. The time series of RR intervals was edited prior to analysis to identify deviations due to ectopic beats, movement artifact or signal noise. Extra or missing beats were replaced with RR intervals calculated by linear interpolation from adjacent cycles. RR intervals for both 5-min segments of the assessment protocol were assessed with fast-Fourier transform to calculate total spectral power, from which HF power (0.15-0.40 Hz) was assessed in units of ms 2 /Hz. HF power was not assessed in normalized units [15] . The magnitude of this index can change due to alteration in low-frequency power (0.04-0.15 Hz), HF power or a combination of both, and our principle interest was to concentrate on RR HF power as a marker of vagal compared with vagal/sympathetic HR modulation.
Respiration rate was recorded with a strain gauge belt (Resp-Flex Pro; Thought Technology) that measured thoracic movement at 32 samples/s. These data were synchronized with the ECG data during acquisition. HF power for variability in respiration was calculated with MATLAB, as described above.
Statistical analysis
Results are expressed as means + − S.E.M., with P < 0.05 from a two-tailed test as the criterion for significance. Log transformations were made on CRP values, as well as indices of HF spectral power from RR intervals and respiratory variability, in order to normalize the sampling distributions. RR and respiratory logHF means during the silent reading baseline and self-guided relaxation procedure were assessed with repeated-measures AN-OVA, using the Greenhouse-Geisser correction. Potential correlates of RR logHF power during behavioural relaxation were identified with Pearson correlations. Hierarchical linear regression analysis was then used to assess the degree to which CRP accounted for variance in RR logHF power during behavioural relaxation, while controlling for potential confounding influences. Baseline RR interval was entered into the regression equation at the initial step of the hierarchy. The following predictor variables competed for stepwise entry at step 2: respiratory logHF power during behavioural relaxation, β-blockade, ACE (angiotensin-converting enzyme) inhibition and BMI (body mass index). These predictors were selected on the basis of a significant bivariate correlation with RR logHF power or because of baseline differences between Low-and High-CRP groups. CRP competed for stepwise entry at step 3 of the regression hierarchy. Statistical analyses were performed using SSPS 12.0.
RESULTS
Sample characteristics
The sample was comprised of 29 patients with CAD (four female and 25 male) who represented the first and fourth quartiles in the distribution of CRP that was obtained from 56 prospective recruits: Low-CRP group (n = 14), 0.47 + − 0.07 µg/ml; and High-CRP group (n = 15), 8.19 + − 1.95 µg/ml. CRP values obtained from blood assays immediately before and after the behavioural assessment protocol were highly correlated (r = 0.996, P < 0.001). Therefore only the CRP values following the behavioural assessment were utilized for this investigation. The mean age of subjects in the first and fourth CRP quartiles was 62.12 + − 1.65 years. Anthropometric data, medical history and medication are summarized in Table 1 .
Behavioural relaxation and vagal HR control
The interaction between behavioural assessment procedures and (Low-compared with High-) CRP groups was not statistically significant, with RR logHF power as the dependent variable [F(1,27) = 1.03; P = 0.32]. A significant main effect was observed for the CRP groups across the behavioural assessment tasks. The Low-CRP group (2.31 + − 0.11) had a significantly greater RR logHF power compared with the High-CRP group (1.97 + − 0.11) across the silent reading baseline and self-guided relaxation procedures [F(1,27) = 5.10; P = 0.032].
A significant main effect according to the behavioural assessment task was observed. RR logHF power increased significantly from the silent reading baseline (2.11 + − 0.08) to self-guided relaxation (2.17 + − 0.08) for both Low-and High-CRP groups [F(1,27) = 5.04; P = 0.033].
Respiration rate increased significantly from the silent reading baseline (14.59 + − 0.65) to self-guided relaxation Table 2 shows the Pearson correlations for RR logHF power during behavioural relaxation. In addition to CRP, potential confounding factors were examined that included RR interval during the silent reading baseline, respiratory logHF during self-guided relaxation, cardiac medication and BMI.
CRP and vagal HR modulation
A hierarchical linear regression analysis examined the association between RR logHF power during behavioural relaxation and CRP. The influence of baseline RR interval was statistically controlled by entering it into the regression equation at step 1 of the hierarchy. It accounted for 38.5 % of the variance in RR logHF power (P < 0.001). Predictor variables at the second step of the hierarchy included respiratory logHF power during behavioural relaxation, β-blockade, ACE inhibition and BMI. Only β-blockade passed the stepwise entry criteria of P < 0.05, and explained variance in RR logHF power during behavioural relaxation increased to 49.7 % (P < 0.001). CRP was allocated a priori to step 3 of the regression hierarchy. It passed the stepwise entry criteria with a significant inverse association with RR logHF power during relaxation (partial correlation, − 0.43; P = 0.028).
Explained variance increased to 57.4 % (P < 0.001). As shown in Table 3 , β-blockade only demonstrated a trend towards a significant association with RR logHF power (P = 0.077) once CRP entered the regression equation, whereas baseline RR interval continued to significantly account for variance in RR logHF power. In Table 3 Hierarchical linear regression on RR logHF power during self-guided relaxation in patients with CAD
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DISCUSSION
The present study reports a novel finding regarding the influence of systemic inflammation, as assessed by CRP, on vagal HR regulation, as inferred from RR logHF power. Patients with CAD significantly increased in RR logHF power from a baseline silent reading procedure to self-guided behavioural relaxation. Interestingly, CRP levels moderated RR logHF power not only at baseline, but also during behavioural relaxation when inhibitory influences on vagal HR control would be expected to be diminished. Hierarchical linear regression determined that CRP independently accounted for 18.9 % of the variance in RR logHF power during behavioural relaxation. This association was independent of confounding factors, including β-blockade, ACE inhibition, BMI, RR interval during a silent reading baseline and respiratory logHF power during the behavioural relaxation procedure.
The results of the present study extend previous research in two ways. The association between decreased HRV and systemic inflammation has been reported previously among high-risk populations without established CAD [11, 16] . The present study reports a similar observation among patients with CAD, while focusing on an HRV marker of vagal HR control. In addition, our findings, in combination with previous research, suggest that the inhibitory influence of systemic inflammation on HRV is stable during ambulatory 24-h monitoring and during brief recordings in a controlled laboratory setting [11, 16] .
RR logHF power and vagal HR modulation
A constructive debate continues to evolve about the quantification and neurophysiological basis of HRV indices [17, 18] . Two issues highlighted in this debate are relevant to the interpretation of our present findings. First, RR interval variation is an end-organ behaviour that is regulated by complex, redundant and interacting mechanisms, such as the baroreflex, chemoreflex, cardiopulmonary mechanoreflex and metaboreflex. It is unclear how changes in RR logHF power reflect the coordinated integration of these regulatory mechanisms. Nevertheless, the use of RR logHF power as a marker of vagal HR control is supported by related research that modelled a quantitative association between RR HF spectral power and incremental vagal blockade with atropine [19] . A correspondence between increased RR HF power and augmented vagal HR control has also been reported in laboratory studies and clinical trials through the use of interventions such as β-blockade and ACE inhibition [3, 20, 21] .
The potential influence of baseline RR interval and cardiac medication on RR logHF power were closely examined in the present study. RR interval during the baseline silent reading assessment was numerically greater among the Low-compared with High-CRP group, although this difference was not statistically significant, perhaps due to our small sample size. β-Blockade was more prevalent in the Low-CRP group (P = 0.014), but no group differences were found with the other cardiac medication. Withdrawal of all cardiac medication prior to our assessment would have provided additional methodological rigour for the analysis of RR logHF power. Nevertheless, the hierarchical linear regression analysis statistically controlled for the potential confounding influence of cardiac medication, respiration and BMI. As noted above, CRP was independently and inversely associated with RR logHF power during behavioural relaxation. Once CRP was entered into the regression equation, β-blockade only approached statistical significance (P = 0.077), and the other predictor variables failed to significantly account for additional variance. This finding is consistent with the hypothesis that elevated systemic inflammation, as measured by CRP, has an inhibitory effect on vagal HR modulation.
The second issue that has a bearing on our present findings concerns the interpretation of how subjects may have increased RR logHF power during self-guided relaxation. Respiratory rate increased modestly, but significantly, in all of the subjects in our present study, from approx. 14 breaths/min during silent reading to 15 breaths/ min during relaxation. Respiratory rate and tidal volume are well known to influence the gain of RR HF power [22] . Respiratory frequency is inversely associated with the amplitude of RSA (respiratory sinus arrhythmia) and HF spectral power, and it contributes maximal gain when respiration is between 6 and 10 breaths/min [22, 23] . It is therefore unlikely that an increase in respiratory frequency could have contributed to the rise in RR HF power during behavioural relaxation. On the other hand, tidal volume was not assessed in our present study. It is possible that the increase observed in RR logHF power during self-guided relaxation was due to a spontaneous increase in tidal volume compared with a change in neurocardiac regulation that is hypothesized to result from cognitive-emotional relaxation. Nevertheless, the influence of tidal volume on RSA amplitude or RR HF power has been shown to diminish as respiration rate increases, particularly above the threshold of 10 breaths/ min [22, 23] . In a segment of a study by Poyhonen et al. [24] , healthy controls were directed to increase and decrease tidal volume by 20 % from baseline while respiration was maintained at 12 breaths/min. RR logHF power did not change significantly from baseline following the 20 % increase in tidal volume, but it was reduced significantly when tidal volume was decreased by 20 %. RR logHF power also differed significantly in the (40 %) contrast between increased compared with decreased tidal volume. In summary, the significant increase that we observed in RR logHF power with behavioural relaxation may have resulted from a marked increase in tidal volume, which was sufficient in magnitude to override the inhibitory effects on HF power associated with the increased respiratory rate. Our casual observations do not support this interpretation, but this important issue merits follow-up investigation.
Inflammatory influences on neuroendocrine and autonomic control of HR
Our present finding of an independent association between CRP and reduced vagal HR control (RR logHF power) could be mediated by several peripheral or central mechanisms that regulate immune and autonomic functioning. CRP is synthesized by hepatocytes under the control of IL-6 and, to a lesser extent, IL-1β and TNF-α, after which it is released into the systemic circulation [25, 26] . Blood-borne markers of inflammation, such as IL-1β, IL-6 and CRP, can influence the autonomic regulation of cardiovascular function through humoral and neural anti-inflammatory responses that result in enhanced local and systemic availability of glucocorticoids and catecholamines [27, 28] .
Pro-inflammatory cytokines (e.g. IL-1β) are well known to cross the blood-brain barrier at vulnerable sites in the circumventricular organs, through active transport or stimulation of afferent vagal or sympathetic fibres in the periphery, with the effect of triggering the expression of inflammatory cytokines in brain sites that integrate activity of the HPA axis and sympathetic nervous system, such as the hypothalamic PVN (paraventricular nucleus) [28, 29] . Animal models have demonstrated that PVN reactivity to systemic administration of IL-1β increased the number of Fos-positive catecholamine cells in regions of the medulla that control tonic sympathetic outflow to the heart: A1 and C1 noradrenergic cells, as well as C1 and C2 adrenergic cells [30] . A parallel study demonstrated that PVN reactivity to inflammatory challenge with LPS (lipopolysaccharide) significantly elevated HR, and this was associated with Fos-like immunoreactivity in similar brainstem sites, including the locus coeruleus, A1/C1 and A5 cell groups, and the nucleus of the solitary tract [31] .
Given the above findings, it is reasonable to infer that patients with CAD with elevated systemic inflammation may be less able to counter daily challenges that trigger sympathetic HR activation or vagal HR inhibition by means of behavioural-coping procedures, such as selfguided relaxation. Previous evidence is consistent with this possibility. Steptoe et al. [10] assessed cardiovascular and pro-inflammatory reactivity to mental stress among healthy adults. They reported an independent association between acute responses of systolic and diastolic BP and HR during testing, and delayed elevation in IL-6, IL-1Ra, and TNF-α.
In the context of HRV investigations in patients with CAD, the cholinergic anti-inflammatory pathway could be expected to potentially buffer the chronotropic effects of glucocorticoid or catecholamine activation in the heart [32] . Our finding that elevated CRP was associated with decreased logHF suggests that vagal efferent control of HR may be inhibited in the presence of chronic systemic inflammation. However, our study did not examine vagal HR control in relation to pro-inflammatory cytokines (e.g. TNF-α) or immune challenge (e.g. LPS administration), and these factors would need to be considered to investigate this possibility directly. At the same time, our findings suggest that it may be possible to augment vagal efferent control of HR with behavioural procedures in order to enhance cardioprotection from autonomic and immune disturbances that may be triggered by recurrent environmental challenges [5, 10] . Evidence exists to show that behavioural training in relaxation and HRV biofeedback can augment BRS and vagal HR modulation [33] [34] [35] .
A limitation of the present study is the small sample size. Nevertheless, a robust inverse association between CRP and vagal HR modulation was detected in spite of compromised statistical power. Replication with a larger sample and a more focused methodology is necessary to confirm our observations and to examine the potential mediating influence of respiratory and pro-inflammatory factors in more detail. Also, our present study was not designed to address whether the independent association between CRP and vagal HR control during behavioural relaxation was stable over time. In addition, the present observations may underestimate the potential ability of behavioural relaxation to augment vagal HR control, since subjects were not provided with training in a formal relaxation procedure.
In summary, neuroregulation of HR in patients with CAD is significantly influenced by interactions between the immune and autonomic systems. Previous research has noted that systemic inflammation is associated with sympathetic cardiac activation and decreased HRV. The present study extends this work by observing that systemic inflammation, measured by CRP, was independently associated with decreased vagal HR control in patients with CAD, as inferred from spectral analysis of the RR interval. In addition, self-guided behavioural relaxation increased the spectral marker of vagal HR control, but this index was modulated by the severity of systemic CRP. It may be advisable to assess the potential moderating influence of systemic inflammation on autonomic HR control when investigating the effect of behavioural interventions on HRV among CAD patients.
